IGC Pharma (IGC) Long-Term Debt Repayments (2016 - 2025)
Historic Long-Term Debt Repayments for Pharma (IGC) over the last 14 years, with Q3 2025 value amounting to $1000.0.
- Pharma's Long-Term Debt Repayments changed 0.0% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of -$3000.0 for FY2025, which is 0.0% changed from last year.
- As of Q3 2025, Pharma's Long-Term Debt Repayments stood at $1000.0, which was down 0.0% from $1000.0 recorded in Q2 2025.
- Over the past 5 years, Pharma's Long-Term Debt Repayments peaked at $3000.0 during Q3 2023, and registered a low of -$7000.0 during Q1 2025.
- In the last 5 years, Pharma's Long-Term Debt Repayments had a median value of $1000.0 in 2021 and averaged -$666.67.
- As far as peak fluctuations go, Pharma's Long-Term Debt Repayments crashed by 20000.0% in 2022, and later surged by 40000.0% in 2023.
- Over the past 5 years, Pharma's Long-Term Debt Repayments (Quarter) stood at $1000.0 in 2021, then tumbled by 200.0% to -$1000.0 in 2022, then plummeted by 400.0% to -$5000.0 in 2023, then surged by 140.0% to $2000.0 in 2024, then tumbled by 50.0% to $1000.0 in 2025.
- Its Long-Term Debt Repayments stands at $1000.0 for Q3 2025, versus $1000.0 for Q2 2025 and -$7000.0 for Q1 2025.